FDA Inspection 1001314 — Cellex-C International Inc.
The FDA completed an inspection of Cellex-C International Inc. on Jan 19, 2017 in Toronto. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection details
- Classification
- Official Action Indicated (OAI)
- End Date
- Jan 19, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Toronto (Canada)